Greek Plans For More Pharma Competition

16 April 1995

Competition is to be introduced in the supply of medicines to state hospitals, Greek Minister of Commerce, Industry and Research, Costas Simitis, has revealed. With this aim in mind, it is proposed to reform the framework which administers cost and distribution of pharmaceuticals in the country.

In addition, it has been proposed to decrease the contributing mixed profits of pharmaceutical suppliers, so that the average levels will be 5% rather than the current 8%, according to a report in Balkan News & East European Report.

Commenting on the situation, Paul Giannacopoulos, president of the Association of Representatives of Pharmaceutical Products and Specialties, told the Marketletter that indeed discussion have been taking place with both the Ministry of Health and the Ministry of Commerce along with representatives of drug manufacturers and imports, covering issues such as price fixing, reference prices, list of social securities and supply of pharmaceuticals to Greek hospitals.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight